Related Experiment Video
Updated: Feb 6, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.7K
Bioinspired Artificial Nanodecoys for Hepatitis B Virus
Xuan Liu1, Lunzhi Yuan2, Liang Zhang2
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 361102, China.
Angewandte Chemie (International Ed. in English)
|August 9, 2018
Summary
Researchers developed novel nanomimics that mimic hepatitis B virus (HBV) receptors to block HBV infection. These engineered vesicles effectively prevented viral spread and replication in cell and animal models, offering new nanomedicine strategies.
Area of Science:
- Biotechnology
- Virology
- Nanomedicine
Background:
- Hepatitis B virus (HBV) poses a significant global health challenge.
- Targeting the HBV receptor is crucial for developing effective antiviral therapies.
Purpose of the Study:
- To develop a novel nanomimic strategy for blocking HBV infection.
- To engineer membrane vesicles that display the HBV receptor (hNTCP) for antiviral applications.
Main Methods:
- Fabrication of hNTCP-anchoring membrane vesicles (hNTCP-MVs) via a natural biosynthetic procedure.
- In vitro testing of hNTCP-MVs against HBV infection in cell models.
- In vivo evaluation of hNTCP-MVs in a human-liver-chimeric mouse model of HBV infection.
Main Results:
- hNTCP-MVs effectively blocked HBV infection in cell cultures.
- Treatment with hNTCP-MVs significantly prevented viral infection, spreading, and replication in mice.
- Demonstrated a receptor-mediated antiviral effect by 'tricking' HBV.
Conclusions:
- hNTCP-MVs represent a promising nanomedicine approach for combating HBV infection.
- This strategy offers a new avenue for developing receptor-mediated antiviral therapies.
- Further development of these nanomimics could lead to novel treatments for HBV.
Related Concept Videos
00:50What are Viruses?
128.3K
Overview
128.3K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
01:21Hepatic Portal System
6.0K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.0K
01:24Natural and Artificial Concepts
576
In psychology, concepts can be divided into two categories: natural and artificial. Natural concepts are formed through direct or indirect experiences. For example, consider the concept of snow. If you live in a place with regular snowfall, such as Essex Junction, Vermont, you know snow through direct experiences. You’ve seen it fall, touched it, shoveled it, and played in it. You recognize its texture, appearance, and even its smell. In contrast, if you live on an island like Saint...
576
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
247
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
247
01:16Hepatic Drug Excretion: Influencing Factors
592
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
592